MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger AB.
Wei J, et al. Among authors: gilbert mr.
Neuro Oncol. 2016 May;18(5):639-48. doi: 10.1093/neuonc/nov292. Epub 2015 Dec 11.
Neuro Oncol. 2016.
PMID: 26658052
Free PMC article.